CompletedNot Applicable

Effect of vitk2 on Atopic Dermatitis Pediatrics Patients

Egypt100 participantsStarted 2024-08-03

Plain-language summary

investigate the effectiveness and safety of adding vitamin K2 at a dose of 45 mg/day for 12 weeks to conventional therapy for paediatric patients with moderate to severe atopic dermatitis according to SCORAD score

Who can participate

Age range6 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients aged 6-12 years * moderate to severe AD according to SCORAD score Exclusion Criteria: * other cutaneous allergic diseases (urticaria, angioedema, anaphylaxis, contact dermatitis). * primary immunodeficiency (PID) with cutaneous allergic manifestations.

What they're measuring

to evaluate the impact of vitamin K2 on the severity of atopic dermatitis, as assessed by the SCORAD score

Timeframe: at baseline and after 3months

Trial details

NCT IDNCT07574242

SponsorOctober 6 University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-05

View on ClinicalTrials.gov More Atopic Dermatitis trials